August 23, 2024
TOPLINE: There is no link between the COVID-19 vaccination and an increased risk for multiple sclerosis (MS) relapse in most patients. However, there is a small […]
August 23, 2024
TOPLINE: Treatment with etanercept led to faster disease control initially in patients with early rheumatoid arthritis (RA) who had an insufficient early response to methotrexate and […]
August 23, 2024
TOPLINE: Quitting smoking significantly lowered the risk of developing hidradenitis suppurativa (HS), with this reduction becoming evident 3-4 years after cessation, in a cohort study from […]
August 22, 2024
TOPLINE: Elinzanetant significantly reduced the frequency and severity of vasomotor symptoms in menopausal women by week 12. The drug also improved sleep disturbances and menopause-related quality […]
August 22, 2024
TOPLINE: In patients with small, peripheral non–small cell lung cancer (NSCLC), visceral pleural invasion leads to worse disease-free and recurrence-free survival as well as higher rates […]
August 22, 2024
TOPLINE: Older adults with untreated hypertension have a 36% increased risk for Alzheimer’s disease (AD) compared with those without hypertension and a 42% increased risk for […]
August 22, 2024
TOPLINE: Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for all-cause mortality and major adverse cardiovascular events (MACE) than for dipeptidyl […]
August 22, 2024
TOPLINE: In patients with type 2 diabetes (T2D) and metabolic dysfunction–associated steatotic liver disease (MASLD), the risk for major liver outcomes appears similar with dipeptidyl peptidase […]
August 21, 2024
TOPLINE: Belzutifan demonstrated a significant benefit over everolimus in progression-free survival and objective response rates in advanced renal cell carcinoma. At 18 months, 24% of participants […]